Certified Advisory Corp purchased a new stake in shares of Ventas, Inc. (NYSE:VTR) during the fourth quarter, HoldingsChannel reports. The fund purchased 1,709 shares of the real estate investment trust’s stock, valued at approximately $102,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of VTR. Valeo Financial Advisors LLC boosted its position in Ventas by 1,945.6% during the fourth quarter. Valeo Financial Advisors LLC now owns 1,841 shares of the real estate investment trust’s stock valued at $110,000 after acquiring an additional 1,751 shares during the last quarter. Aevitas Wealth Management Inc. bought a new stake in Ventas during the fourth quarter valued at $114,000. Icon Wealth Partners LLC bought a new stake in Ventas during the fourth quarter valued at $114,000. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC bought a new stake in Ventas during the fourth quarter valued at $116,000. Finally, Amica Retiree Medical Trust bought a new stake in Ventas during the third quarter valued at $131,000. 88.78% of the stock is currently owned by institutional investors and hedge funds.
Ventas stock opened at $48.11 on Friday. The stock has a market cap of $17,567.09, a PE ratio of 12.76, a PEG ratio of 3.21 and a beta of 0.14. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a 1 year low of $47.94 and a 1 year high of $72.36.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 12th. Investors of record on Monday, April 2nd will be issued a $0.79 dividend. The ex-dividend date of this dividend is Thursday, March 29th. This represents a $3.16 dividend on an annualized basis and a dividend yield of 6.57%. Ventas’s dividend payout ratio is presently 83.82%.
VTR has been the topic of a number of research analyst reports. BMO Capital Markets reaffirmed a “sell” rating and set a $63.00 price target on shares of Ventas in a research report on Monday, November 27th. Zacks Investment Research cut shares of Ventas from a “hold” rating to a “sell” rating in a research report on Wednesday, November 29th. UBS cut shares of Ventas from a “market perform” rating to an “underperform” rating in a research report on Monday, December 4th. Raymond James Financial reissued an “underperform” rating on shares of Ventas in a research report on Monday, December 4th. Finally, ValuEngine raised shares of Ventas from a “hold” rating to a “buy” rating in a research report on Friday, January 5th. Six analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the stock. Ventas currently has a consensus rating of “Hold” and an average target price of $58.23.
ILLEGAL ACTIVITY WARNING: This news story was first reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3298461/certified-advisory-corp-purchases-shares-of-1709-ventas-inc-vtr.html.
Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.